Boston Scientific is moving ahead with a major expansion in the United States, announcing plans to establish a new global distribution center in Plainfield, Indiana. The Marlborough, Massachusetts-based medical technology company expects the project to generate as many as 300 high-wage positions and strengthen its distribution capabilities for medical devices worldwide. The development represents the latest step in the company’s ongoing growth strategy following previously announced investments, including an $88 million R&D commitment in Ireland and a facility expansion in Maple Grove, Minnesota, during 2026.
According to information released by Indiana Governor Mike Braun’s office, the Boston Scientific investment is valued at $138 million. The company plans to build and equip a 500,000-square-foot facility within Plainfield Innovation Park. Once operational, the site is expected to reinforce and expand the company’s U.S.-based logistics and distribution network while supporting broader global operations.
The planned facility will incorporate advanced technology along with light manufacturing capabilities. Boston Scientific said the site will include the processes and operational infrastructure required to meet regulatory compliance requirements. Upon completion, the center will assume responsibility for the global distribution of the company’s medical devices, making it a key component of its supply chain and logistics framework.
Construction is scheduled to begin later this year. Commenting on the announcement, Braun said: “Indiana’s commitment to further advancing our already robust life sciences sector continues to pay dividends as we welcome Boston Scientific to Plainfield. This new facility can bolster the state’s global leadership in life sciences and medical device innovation while creating hundreds of high-skilled, high-wage jobs, providing more opportunities for Hoosiers to advance their skills, grow their careers and provide for their families.” The Boston Scientific project is expected to further strengthen Indiana’s position as a hub for life sciences and medical device operations.
